Considering the beneficial effects of GcgR antagonists on glycaemia [66,67,68], it would seem counterintuitive to employ agonism in a therapy for obesity and, certainly, diabetes
Omeprazole is not listed as a contraindication or a flagged interaction on the Wegovy label, and the manufacturer's own pharmacokinetic testing found no clinically significant differences in semaglutide exposure when the two were given together but "no known interaction" is not the same as "no reason to tell your prescriber," and the reason people ask this question at all is worth unpacking
Two main forms of the A protein have been identified: A40 and A42, which contain 40 and 42 amino acid residues respectively (Sambamurti et al., 2002)
This pool combined 13 placebo-controlled trials, including 3 monotherapy trials, 9 add-on to background antidiabetic therapy trials, and an initial combination with metformin HCl trial
Int J Mol Sci 24(3):2633 Zhang F, Li X, Wei Y (2023) Selenium and selenoproteins in health